Manik Chhabra

Manik Chhabra

Auto-generated profile, based on publicly available information

Manik Chhabra

Department of Epidemiology and Biostatistics, Western University, London, ON, Canada; ICES, Toronto, ON, Canada; London Health Sciences Centre Research Institute, London Health Sciences Centre, London, ON, Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2020 in Current Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
MRMuhammad Rashid
Muhammad Rashid
MCManik Chhabra
Manik Chhabra
AKAnanth Kashyap
Ananth Kashyap
KUKrishna Undela
Krishna Undela
SGSai Krishna Gudi
Sai Krishna Gudi
Background: Self-Medication (SM) is a practice of using medications to treat selfdiagnosed symptoms without a legitimate prescription by a health care professional. Alongside posing a burden on a patient, SM practices are associated with certain unfavourable health conditions such as drug-resistance, adverse effects, drug-interactions, including death. Objective: To systematically review and quantify the prevalence of SM practices and its associated factors in India. Methodology: A comprehensive systematic search was performed using scientific databases such as PubMed and Cochrane library for the peer-reviewed research articles that were conducted in India without any language and date restrictions. Studies which were cross-sectional by design and assessing the prevalence and predictors of SM practices in India were considered for the review, and all the relevant articles were screened for their eligibility. Results: Of 248 articles, a total of 17 articles comprising of 10,248 participants were included in the meta-analysis. Overall, the mean prevalence of SM practices in India was observed to be 53.57%. Familiarity with the medication appears to be a major reason to practice SM (PR: 30.45; 95% Confidence Interval [CI]: 17.08-43.82; 6 studies), and the practice was noticed more among individuals from a middle-lower class family with a prevalence rate of 26.31 (95%CI: 2.02-50.60; P<0.0001). Minor ailments were the primary reason for practicing SM (PR: 42.46; 95%CI: 21.87- 63.06), among which headache was the most commonly reported (PR: 41.53; 95%CI: 18.05-65.02). Conclusion: Self-medication practices are quite frequent in India. While NSAIDs and anti-allergens are the most frequently utilized self-medicated drugs used for headache and cold and cough.

17 May 2019 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
SGSai Krishna Gudi
Sai Krishna Gudi
AKAnanth Kashyap
Ananth Kashyap
MCManik Chhabra
Manik Chhabra
MRMuhammad Rashid
Muhammad Rashid
KTKomal Krishna Tiwari
Komal Krishna Tiwari
OBJECTIVES: To address and elucidate the impact of pharmacist-led home medicines review (HMR) services on identifying drug-related problems (DRPs) among the elderly population in home care settings.METHODS: A comprehensive systematic search was performed using electronic scientific databases such as PubMed, Scopus, Embase, and Web of Science for studies published between January 1, 2008 and December 31, 2018, pertaining to HMR services by pharmacists for identifying DRPs.RESULTS: In total, 4,292 studies were retrieved from the searches, of which 24 were excluded as duplicates. Titles and abstracts were screened for the remaining 4,268 studies, of which 4,239 were excluded due to the extraneous nature of the titles and/or abstracts. Subsequently, 29 full-text articles were assessed, and 19 were removed for lacking the outcome of interest and/or not satisfying the study’s inclusion criteria. Finally, 10 studies were included in the review; however, publication bias was not assessed, which is a limitation of this study. In all studies, pharmacists identified a highly significant amount of DRPs through HMR services. The most common types of DRPs were potential drug-drug interactions, serious adverse drug reactions, need for an additional drug, inappropriate medication use, non-adherence, untreated indications, excessive doses, and usage of expired medications.CONCLUSIONS: HMR is a novel extended role played by pharmacists. The efficiency of such programs in identifying and resolving DRPs could minimize patients’ health-related costs and burden, thereby enhancing the quality of life and well-being among the elderly.

1 February 2020 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
MRMuhammad Rashid
Muhammad Rashid
ARAsha K Rajan
Asha K Rajan
MCManik Chhabra
Manik Chhabra
AKAnanth Kashyap
Ananth Kashyap

22 April 2019 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
JRJ. Rahmani
J. Rahmani
NMN. Manzari
N. Manzari
JTJ. Thompson
J. Thompson
SGSai Krishna Gudi
Sai Krishna Gudi
MCM. Chhabra
M. Chhabra
YZYong Zhang
Yong Zhang

17 November 2020 in Pharmacy
Verified
Journal Article
Open access
PDF file
RSRishabh Sharma
Rishabh Sharma
MCManik Chhabra
Manik Chhabra
KVKota Vidyasagar
Kota Vidyasagar
MRMuhammad Rashid
Muhammad Rashid
DFDaniela Fialová
Daniela Fialová
Akshaya BhagavathulaAkshaya Bhagavathula
Akshaya Bhagavathula
Background: Older patients with type 2 diabetes mellitus (T2DM) are at greater risk of receiving potentially inappropriate medications (PIM) during hospitalization which may result in adverse outcomes. Aim: To evaluate the extent of PIM use in the older population with T2DM during hospitalization in a tertiary care hospital in India. Methods: A cross-sectional study was carried out from August 2019 to January 2020 in a tertiary care teaching hospital among the older population (aged ≥ 65 years) hospitalized with T2DM. Medications prescribed during hospitalization were reviewed following Beers Criteria 2019 to identify the extent of polypharmacy and PIM use. Binary logistic regression was applied to determine the factors associated with PIM use. Results: The mean age of the 150 patients hospitalized with T2DM was 68.85 ± 5.51 years, most of whom were men (54.7%). The participants had at least four comorbidities and were receiving an average of nine medications per day; the median length of hospital stay was 8 days (interquartile range (IQR): 4–19 days). Overall, three quarters (74%) of the participants had at least one PIM prescribed during their hospitalization as per Beers Criteria. Significant factors associated with the use of PIM during hospitalization are patients taking a higher number of medications (odds ratio (OR): 7.85, 95% CI 1.49–41.10), lower creatinine clearance values (OR: 12.90, 95% CI 2.81–59.28) and female patients (OR: 2.29; 95% CI: 1.05–4.97). Conclusions: PIM use is frequently observed in older T2DM patients during hospitalization. Polypharmacy, reduced renal function and female gender are associated with higher PIM use. Engaging clinical pharmacists in evaluating medication appropriateness can improve the outcomes of older patients.

19 November 2020 in Journal of Basic and Clinical Physiology and Pharmacology
Verified
Journal Article
Closed access
PDF file
NDNagita Devi
Nagita Devi
CBChandrasekhar Boya
Chandrasekhar Boya
MCManik Chhabra
Manik Chhabra
DBDipika Bansal
Dipika Bansal
Objectives: The objective of this study is to explore the efficacy and safety of N -acetyl-cysteine (NAC) as adjuvant therapy in female infertility. Content: We performed a systematic literature search of PubMed, Cochrane Library, Embase, and Ovid databases through April 2019 for Randomized Controlled Trials (RCTs) evaluating the effectiveness and safety of NAC as adjuvant therapy in female infertility. The outcomes assessed were rates of ovulation, pregnancy, miscarriage and multiple pregnancy, presented as pooled odds ratio with 95% confidence interval (CI) using the random-effects model. Heterogeneity and inconsistency of the measurements were identified through Cochrane’s Q statistic and I2 statistic. We also performed a sensitivity analysis, publication bias (using funnel plot and Begg’s test), and subgroup analysis. Summary: Fifteen RCTs recruiting 2330 female receiving NAC were included. The pooled estimate showed the statistically insignificant improvement in outcomes; clinical pregnancy rate 1.55 (95% CI 0.98–2.47; I2=68%; p<0.01), ovulation rate 1.77 (95% CI 0.76–4.14; I2=90%; p<0.01), multiple pregnancy rate 0.83 (95% CI 0.34–1.99; I2=10%; p=0.31) and miscarriage rate 0.76 (95% CI= 0.37, 1.53; I2=0%; p=0.69) . NAC was found less efficacious and safe than metformin in all outcomes. Overall, NAC showed statistically insignificant (OR=0.98–2.47). Outlook: NAC can be an effective adjuvant in PCOS related and unexplained female infertility. The effect could be more profound in women with high BMI, insulin resistance, and oxidative stress. However, the findings need further confirmation in well-designed randomized controlled trials to examine clinical outcomes such as live birth rate in more extended follow-up periods.